Morning Briefing
Summaries of health policy coverage from major news organizations
Agencies Probe Merck For Foreign Anti-Bribery Law Violations
Merck, the second biggest international drug maker, is being investigated by two U.S. federal agencies for potentially breaking anti-bribery laws in foreign countries.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
